Literature DB >> 18628507

Angio-oedema as an unusual tolerable side effect of voriconazole therapy.

Serap Gençer1, Serdar Özer1, Güler Demirhan1, Öznur Ak1, Ayşe Batırel1.   

Abstract

Voriconazole (VRC) has not previously been reported to cause angio-oedema. Here, we report a case of angio-oedema associated with VRC therapy. A 37-year-old woman with relapsing invasive vertebral aspergillosis received intravenous VRC and developed angio-oedema 10 days after starting therapy. This condition rapidly diminished after administration of intravenous antihistaminics and did not necessitate cessation of VRC treatment. The treatment was continued for 6 months without recurrence of the symptoms. After 18 months, the patient was in good health. To our knowledge, this is the first report of an angio-oedema associated with VRC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628507     DOI: 10.1099/jmm.0.47299-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  1 in total

1.  Lack of allergic cross-reactivity between fluconazole and voriconazole.

Authors:  Angie Pinto; Raymond C Chan
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.